Anika Therapeutics | ANIK - EPS Earnings Per Share


Anika Therapeutics reported $0.13 in EPS Earnings Per Share for its fiscal quarter ending in December of 2025.





Eps Change Date
Abbott USD 1.31 0.16 Jun/2026
Agenus USD 1.02 1.32 Mar/2026
Agios Pharmaceuticals USD -1.69 0 Jun/2026
Anika Therapeutics USD 0.13 0.35 Dec/2025
Arrowhead Research USD -1.36 0.43 Jun/2026
Enanta Pharmaceuticals USD -1.05 0.31 Dec/2024
Halozyme Therapeutics USD 2.28 0.68 Jun/2026
Heron Therapeutics USD -0.02 0.02 Dec/2025
Insmed USD -0.06 0.7 Jun/2026
Integra LifeSciences USD 0.56 0.02 Jun/2026
Intrexon USD -0.1 0.03 Jun/2024
J&J USD 2.9 0.2 Jun/2026
Karyopharm Therapeutics USD -1.02 1.2 Mar/2026
Ligand Pharmaceuticals USD 2.37 0.74 Jun/2026
MacroGenics USD -0.58 0.36 Mar/2026
Merit Medical Systems USD 1.19 0.33 Jun/2026
Rigel Pharmaceuticals USD 0.7 0.76 Sep/2024
Sangamo BioSciences USD -0.18 0.1 Jun/2024
Sanofi EUR 2.09 0.21 Jun/2026
Smith & Nephew USD 0.47 0.12 Jun/2026
Stryker USD 3.69 1.09 Jun/2026
Veracyte USD 0.54 0.02 Jun/2026
Xencor USD -0.29 1.42 Jun/2026
Zimmer Biomet Holdings USD 2.07 0.02 Jun/2026